Skip to main content

Advertisement

SpringerLink
Log in

The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

In order to test the validity of the selected surgical technique as a way to manage persistent synovitis of the knee joint, as well as to slow down the cartilage and bone destruction, we studied the dynamics of biomarkers of inflammatory conditions, and bone and cartilage destruction after total arthroscopic synovectomy (TAS) of the knee joint.

Methods

The sampling comprised 124 RA patients (158 knees) who had undergone the TAS procedure between 2003 and 2015. Before surgery the rheumatoid factor (IgM), C-reactive protein (CRP), erythrocyte sedimentation rate test was completed for all patients. Blood serum samples were collected (prior to surgery, and three, six and 12 months after surgery) and frozen at −70°С. The content of CRP, Matrix metalloproteinase-3 (MMP-3), Cartilage Oligomeric Matrix Protein, as well as cross-linked Ctelopeptides of types I and II were measured in blood serum by means of polarization fluoroimmunoassay with the use of a standard set of reagents.

Results

The average duration of the disease in the studied group was 8.7 ± 6.6 years. Concentration of the inflammation markers showed that only MMP-3 displayed statistical significance.

Conclusions

The obtained results can be used as basis in assessing the efficiency and effectiveness of this method of treatment of persistent knee joint synovitis associated with the RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Åhlén M, Roshani L, Lidén M, Struglics A, Rostgård-Christensen L, Kartus J (2015) Inflammatory cytokines and biomarkers of cartilage metabolism 8 years after anterior cruciate ligament reconstruction: results from operated and contralateral knees. Am J Sports Med 43(6):1460–1466

    Article  PubMed  Google Scholar 

  2. Arnett FC, Edworth SM, Bloch DA, et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-24. https://doi.org/10.1002/art.1780310302

  3. Benucci M, Meacci F, Manfredi M, Gobbi FL, Infantino M, Ricci C, Sarzi-Puttini P, Atzeni F (2014) Can Tocilizumab decrease cartilage Oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis? Curr Rheumatol Rev 10(2):131–135

    Article  CAS  PubMed  Google Scholar 

  4. Boers M, Brooks P, Simon LS et al (2005) OMERACT: an international initiative to improve outcome measurement in rheumatology. Clin Exp Rheumatol 23:10–13

    Google Scholar 

  5. Christgau S, Garnero P, Fledelius C, Moniz C et al (2001) Collagen type. II C-telopeptide fragments as an index of cartilage degradation Bone 29(3):209–215

    CAS  PubMed  Google Scholar 

  6. Chu XQ, Wang JJ, Dou LD, Zhao G (2015) Cartilage oligomeric matrix protein and matrix metalloproteinase-3 expression in the serum and joint fluid of a reversible osteoarthritis rabbit model//. Genet Mol Res 14(4):14207–14215

    Article  CAS  PubMed  Google Scholar 

  7. Crnkic M, Månsson B, Larsson L et al (2003) Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 5(4):181–185

    Article  Google Scholar 

  8. El Defrawy AO, Gheita TA, Raslan HM, El Ansary MM, El Awar AH (2016) Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis. Z Rheumatol 75(9):917–923

    Article  PubMed  Google Scholar 

  9. Fujikawa K, Kawakami A, Tamai M et al (2009) High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion J. Rheumatol 36(6):1126–1129. https://doi.org/10.3899/jrheum.080926

    CAS  Google Scholar 

  10. Houseman M et al (2012) Baseline serum MMP-3 levels in patients with rheumatoid arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up. Arthritis Res Ther 14(1):30. https://doi.org/10.1186/ar3734

    Article  Google Scholar 

  11. Gabay C, Kushner I (1999) Acute phase proteins and other systemic responses to inflammation. Engl J Med 340:448–454

    Article  CAS  Google Scholar 

  12. Galil SM, El-Shafey AM, Hagrass HA, Fawzy F, Sammak AE (2016) Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients. Int J Rheum Dis 19(4):377–384

    Article  PubMed  Google Scholar 

  13. Geiler G, Stiehl P (1974) Significance of the concepts basic activity and actual activity in the morphological evaluation of synovial membranes in rheumatoid arthritis. Z Rheumatol 33:73–86

    CAS  PubMed  Google Scholar 

  14. Karateev DE, Radenska-Lopovok SG, Nasonova VA, Ivanova MM (2003) Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons. Ter Arkh 75(5):12–20

    CAS  PubMed  Google Scholar 

  15. Karmakar S, Kay J, Gravallese EM (2010) Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin N Am 2:385–404

    Article  Google Scholar 

  16. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diag 18(4):481–491

  17. Lohmander LS, Atley LM, Pietka TA, Eyre DR (2003) The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 11:3130–3139

    Article  Google Scholar 

  18. Outerbridge RE (1961) The etiology of chondromalacia patellae. J Bone Joint Surg Br 43:752–757

    PubMed  Google Scholar 

  19. Reijman M, Hazes JM, Bierma-Zeinstra SM et al (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 8:2471–2478

    Article  Google Scholar 

  20. Smolen S, Aletaha D, Steiner G (2009) Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann Rheum Dis 68:159–162

    Article  CAS  PubMed  Google Scholar 

  21. Spector TD, Hart DJ, Nandra D et al (1997) Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressivedisease. Arthr Rheum 40:723–727

    Article  CAS  Google Scholar 

  22. Taylor PC (2002) VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 4:99–107

    Article  Google Scholar 

  23. Tseng S, Reddi AH, Di Cesare PE (2009) Cartilage Oligomeric matrix protein (COMP): a biomarker of arthritis. Biomark Insights 4:33–44

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Turesson C, Bergstrom U, Jacobsson LTH et al (2011) Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis 70:520–522

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation

    Marina Lipina, Maxim Makarov, Sergey Makarov & Alexander Novikov

Authors
  1. Marina Lipina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maxim Makarov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sergey Makarov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexander Novikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina Lipina.

Ethics declarations

Conflicts of interests

The authors reported no conflicts of interest to declare in this article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration ant its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lipina, M., Makarov, M., Makarov, S. et al. The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients. International Orthopaedics (SICOT) 41, 2259–2264 (2017). https://doi.org/10.1007/s00264-017-3634-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-017-3634-8

Keywords

Search

Navigation